543 related articles for article (PubMed ID: 17618574)
1. [Effect of the immune strategy based on BCG priming and Ag85A/GM-CSF DNA vaccine boosting in mice].
Tang Q; Dou J; Zhao FS; Chu LL; Pan M; Wang YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):591-4. PubMed ID: 17618574
[TBL] [Abstract][Full Text] [Related]
2. Investigation of immunogenic effect of the BCG priming and Ag85A- GM-CSF boosting in Balb/c mice model.
Dou J; Tang Q; Yu F; Yang H; Zhao F; Xu W; Wang J; Hu W; Hu K; Liou C; Feng He X; Wang Y
Immunobiology; 2010; 215(2):133-42. PubMed ID: 19450898
[TBL] [Abstract][Full Text] [Related]
3. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
4. Novel constructs of tuberculosis gene vaccine and its immune effect on mice.
Dou J; Chen JS; Wang J; Chen GB; Zhao FS; Tang Q; Fang XS; Chu LL; Pan M
Cell Mol Immunol; 2005 Feb; 2(1):57-62. PubMed ID: 16212912
[TBL] [Abstract][Full Text] [Related]
5. Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A.
Gartner T; Baeten M; Otieno S; Revets H; De Baetselier P; Huygen K
Immunol Lett; 2007 Jul; 111(1):26-35. PubMed ID: 17570535
[TBL] [Abstract][Full Text] [Related]
6. Protection against Mycobacterium tuberculosis challenge in mice by DNA vaccine Ag85A-ESAT-6-IL-21 priming and BCG boosting.
Dou J; Wang Y; Yu F; Yang H; Wang J; He X; Xu W; Chen J; Hu K
Int J Immunogenet; 2012 Apr; 39(2):183-90. PubMed ID: 22152009
[TBL] [Abstract][Full Text] [Related]
7. [Immunogenicity of interleukin 12 and DNA vaccine prime-BCG boost against Mycobacterium tuberculosis].
Gao L; Bao L; Hao M; Zhang L; Qin ZF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):535-9. PubMed ID: 18798487
[TBL] [Abstract][Full Text] [Related]
8. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
9. Comparison of immune responses induced in mice by vaccination with DNA vaccine constructs expressing mycobacterial antigen 85A and interleukin-21 and Bacillus Galmette-Guérin.
Dou J; Tang Q; Zhao F; Chu L; Chen J; Cao M; Liu C; Wang Y; Li Y; Li JL
Immunol Invest; 2008; 37(2):113-27. PubMed ID: 18300037
[TBL] [Abstract][Full Text] [Related]
10. [Immunity characteristics induced by a genetic vaccine expressing Ag85B-ESAT6 fusion protein].
Shi CH; Wang XW; Zhu DS; Xu ZK; Bai YL; Xue Y
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Nov; 28(11):777-80. PubMed ID: 16324275
[TBL] [Abstract][Full Text] [Related]
11. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
[TBL] [Abstract][Full Text] [Related]
12. Improved immunogenicity of recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing fusion protein Ag85A-ESAT-6 of Mycobacterium tuberculosis.
Deng YH; Sun Z; Yang XL; Bao L
Scand J Immunol; 2010 Oct; 72(4):332-8. PubMed ID: 20883318
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
14. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
[TBL] [Abstract][Full Text] [Related]
15. [Immunogenicity of DNA vaccine prime-BCG boost against Mycobacterium tuberculosis].
Gao L; Bao L; Hao M; Zhang HD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Feb; 24(2):122-5. PubMed ID: 18237526
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene.
Zhang X; Divangahi M; Ngai P; Santosuosso M; Millar J; Zganiacz A; Wang J; Bramson J; Xing Z
Vaccine; 2007 Jan; 25(7):1342-52. PubMed ID: 17052817
[TBL] [Abstract][Full Text] [Related]
17. Liposomal oral DNA vaccine (mycobacterium DNA) elicits immune response.
Wang D; Xu J; Feng Y; Liu Y; Mchenga SS; Shan F; Sasaki J; Lu C
Vaccine; 2010 Apr; 28(18):3134-42. PubMed ID: 20197133
[TBL] [Abstract][Full Text] [Related]
18. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
19. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
[TBL] [Abstract][Full Text] [Related]
20. [Specific immune responses in Balb/c mice induced by plasmid coexpressing hepatitis B surface antigen and granulocyte-macrophage colony stimulating factor].
Qing YL; Ling N; Zhao JJ; Peng ML; Xu HM; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):474-6. PubMed ID: 12939179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]